Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Amifostine

U.S. FDA Requirements: Amifostine

Pharmaceutical / Drug Definition : Undergoes conversion to free thiol, an active metabolite that reduces toxic effects of cisplatin on renal tissue

Registrar Corp assists Amifostine companies with:

  • FDA Registration Amifostine
  • FDA Listing Amifostine
  • FDA Label Requirements and Exceptions Amifostine
  • FDA Import Information Amifostine
  • FDA Detentions Amifostine (Amifostine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Amifostine (Amifostine Suppliers)
       - Processors Amifostine
       - Repackers Amifostine
       - Relabelers Amifostine
       - Exporters Amifostine
       - Importers Amifostine
For more information about Amifostine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco